What this Trial Is About

Researchers are studying the factors that increase the risk of complications after endoscopic retrograde cholangiopancreatography (ERCP), a key procedure used to treat various liver, bile duct, and pancreas diseases. This research aims to develop and validate a predictive model to better estimate the chances of adverse events following ERCP. The study also seeks to confirm results from previously published models using new data collected from multiple centers and to assess the rate of complications at these participating sites. The study does not involve experimental treatments but focuses on observing patients undergoing ERCP for their health conditions. Data will be collected to identify patient and procedure-related risk factors and to build a predictive score for adverse events. This will help improve patient information and assist physicians in making better treatment decisions based on individual risk. Participants will be monitored for 14 days after undergoing ERCP to track any complications. Researchers will gather clinical information and evaluate the occurrence of adverse events such as pancreatitis, bleeding, cholangitis, and perforation. The study emphasizes careful follow-up to understand and predict post-ERCP risks, ultimately aiming to enhance patient safety and care management.

Observational Study to Develop a Predictive Score for Adverse Events Post ERCP